• Health: Discovering New Treatments Through AI

    Camille Massiot and Jérémy Bron of Silamir Group present an innovative use case for AI in pharmaceutical research. In partnership with a research laboratory, they have developed a solution for large-scale analysis of patents and biomedical literature, thereby facilitating the discovery of treatments for rare diseases. Using specialized and coordinated AI agents, this solution extracts, enriches, and structures disparate data, providing a significant boost to scientific innovation. Discover how this approach is transforming biopharmaceutical research and how it delivers a real competitive advantage for R&D teams.

    Camille Massiot and Jérémy Bron of Silamir Group present an innovative application of AI in pharmaceutical research. In partnership with a research laboratory, they have developed a solution for large-scale analysis of patents and biomedical literature, thereby facilitating the discovery of treatments for rare diseases.

    Watch the video on YouTube